ZNF264 and myeloid sarcoma: Despite finding four candidate genes (BEX1, BEX2, PALLD, and ZNF264) that were consistently either up- or downregulated in the blood of MS patients in all four datasets, these DE genes were not associated to enriched immunology- or neurology-related terms.